Please note that this page is meant ONLY for Malaysian Pharmacists with a valid Medical Registration Number. Thank you.
Discussing CD30 Testing and its Role in Diagnosing and Treating Peripheral T-cell Lymphomas (PTCL) - Part 2
Presenters : Dr. Noraidah Masir & Dr. Hon Siong Leng
CPD Activity (1.0 credit)
0324/2022
    
About the Course
This e-module is divided into 2 submodules focusing on the diagnosis and management of PTCL.
This module is designed with haematologists and pathologists in mind, to enhance their knowledge and skills, and be equipped to deliver services for patients, public or their profession.
Learning Objectives
Part 1: Practical Approaches in PTCL Diagnosis and the Importance of CD30 Testing
  • Understand the unmet needs and challenges of PTCL diagnosis
  • Understand the practical approaches to PTCL diagnosis and evaluation of common PTCL subtypes from a pathologist's perspective
  • Understand the need for and importance of routine, high-quality CD30 testing and reporting
Part 2: New Directions in Treating Frontline PTCL
  • Understand the unmet needs and challenges of PTCL management
  • Understand the current treatment options and the supporting evidence
  • Understand the role of CD30 expression in the treatment of PTCL
This CPD activity is presented by Dr. Noraidah Masir and Dr. Hon Siong Leng, and is supported by Takeda.
Instructions
Upon successfully obtaining a minimum score of 80%, you will be given 1 CPD point.

About the Presenters

Dr. Noraidah Masir
Consultant Pathologist and Laboratory Director
Pantai Premier Pathology
Prince Court Medical Centre
Dr. Hon Siong Leng
Consultant Clinical Haematologist
Sunway Medical Centre